Market Tracker

10/01 6:05pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

During the Trading Day
4.84 -0.19 / -3.78%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.84 0.00 / 0.00%
 
Volume: 1.8K
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close5.03
Today’s open5.00
Day’s range4.80 - 5.00
Volume210,866
Average volume (3 months)723,653
Market cap$110.7M
Dividend yield--
Data as of 3:59pm ET, 10/01/2014

Growth & Valuation

Earnings growth (last year)-80.56%
Earnings growth (this year)-33.10%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc-0.05-0.56%
TROVTrovagene Inc-0.27-5.90%
QTNTQuotient Ltd0.000.00%
LPDXLipoScience Inc+0.01+0.19%
Data as of 4:14pm ET, 10/01/2014

Financials

Next reporting dateNovember 13, 2014
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$0.00
Annual profit (last year)-$21.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts